Schizophrenia affects over 24 million people worldwide, yet treatment adherence remains a significant challenge due to side effects and complex dosing schedules of oral antipsychotics. Long-acting injectables (LAIs) offer a promising alternative, providing less frequent dosing, improved adherence, and more stable blood concentrations, which may lead to better tolerance and reduced toxicity.

In Module 2 of this podcast, expert Dr. Christoph U. Correll explores new LAI formulations, extended dosing intervals, and improved initiation strategies to help clinicians optimize treatment adherence and improve patient outcomes. Stay informed on the latest advancements in schizophrenia care.

Click here to claim your FREE CME/NCPD/CPE credit:

To hear about advances in treatment of cognitive symptoms associated with schizophrenia, continue to Module 3:

Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology-Oncology, and Professor of Pediatrics at Keck School of Medicine at the University of Southern California (USC), is currently serving as co-chair of i3 Health’s CME/NCPD activity, Practice-Changing Advances in the Management of Hemophilia. With new developments in the field occurring over recent months, Dr. Young sat down with us to share recent updates in the hemophilia treatment and management. Afterwards, stay tuned to hear the full activity and learn how to claim free CME/NCPD credit.

Click the links below for the full activity!

Online accredited CME/NCPD activity: https://i3health.com/course-information/practice-changing-advances-in-the-management-of-hemophilia

Accredited CME/NCPD podcast: https://i3health.com/course-information/practice-changing-advances-in-the-management-of-hemophilia-podcast

Implementing AI Into Healthcare Education: The Ethical and Legal Landscape by i3 Health

Tune in to the latest podcast episode, Best Practices and Emerging Evidence in the Treatment of Atopic Dermatitis in Children and Adolescents, where experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold discuss cutting-edge advancements in pediatric AD care. Learn about new therapies, including nonsteroidal topicals, JAK inhibitors, monoclonal antibodies, and emerging treatments targeting the OX40 pathway, along with practical strategies to optimize patient outcomes. This episode is a must-listen for dermatologists, pediatricians, family medicine physicians, nurse practitioners, PAs, nurses, and other healthcare providers looking to stay current on evidence-based care for children and adolescents with AD.

Earn CME/NCPD credit while you listen!

Click here to claim credit: i3health.com/atopic-dermatitis

Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions.

In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, provides essential insights and testing recommendations to optimize patient care. Listen now!

Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies.

In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, explores advanced testing methodologies and strategies to navigate HER2 complexities and optimize patient outcomes. Listen now!

Gain valuable insights into the complexities of diagnosing and managing dedifferentiated liposarcoma (DDLPS) and earn free CME credit with our latest podcast. This episode features expert guidance from Dr. Richard F. Riedel of Duke University and Dr. Candace L. Haddox of Dana-Farber Cancer Institute. Delve into the latest on identifying MDM2 and CDK4 amplification, challenges in diagnosing DDLPS, and updates on emerging therapies like CDK4/6 inhibitors and immunotherapies. Learn how a multidisciplinary approach enhances patient outcomes in this rare and aggressive soft tissue sarcoma. Listen now and advance your expertise!

Click here to claim your CME credit: https://i3health.com/course-information/podcast-ddlps

Click the links below for the full activity!

Online Accredited CME/NCPD Activity: https://i3health.com/course-information/Alzheimer-disease

Live In-Person or Virtual Meeting: https://i3health.com/live/Exploring%20Advances%20in%20the%20Early%20Diagnosis%20and%20Treatment%20of%20Alzheimer%20Disease

November is National Alzheimer Disease Awareness Month, a time to raise awareness of early warning signs, advocate for research, and show support for the more than 6.2 million Americans living with this disease. Dr. Nathaniel Chin, Associate Professor of Medicine in the Division of Geriatrics and Gerontology at the University of Wisconsin-Madison, is currently serving as chair of i3 Health’s accredited CME/NCPD activity, Exploring Advances in the Early Diagnosis and Treatment of Alzheimer Disease. In honor of National Alzheimer Disease Awareness Month, he sat down with us again to share recent advances in diagnosis and treatment, including those which listeners can learn more about in the activity,

i3 Health is pleased to invite you to Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, a free, live webinar held on November 7 at 10:00 am Eastern and November 19 at 11:30 am Eastern. This interview features an exclusive preview from the two webinar co-chairs, Dr. Filipa Lynce, Director of the Inflammatory Breast Center at Dana-Farber Cancer Center and Assistant Professor of Medicine at Harvard Medical School, and Catherine Skefos, Certified Genetic Counselor in the Clinical Cancer Genetics Program at the University of Texas MD Anderson Cancer Center. Click below to register for this insightful webinar and enhance your understanding of genetic testing and counseling in cancer care!

Register for the webinar: https://i3health.com/course-information/pathways-to-precision-integrating-genetic-counseling-and-testing-into-cancer-care

Dr. Deborah Wong, Director of the Medical Oncology Program and Clinical Trials Program for Head and Neck Squamous Cell Cancers (HNSCC) and an Associate Clinical Professor of Medicine at the University of California Los Angeles (UCLA) is currently serving as co-chair of i3 Health’s accredited CME/NCPD activity, Recurrent and Metastatic HNSCC, Harnessing Immunotherapy and Comprehensive Care. With new developments in the field occurring over recent months, Dr. Wong sat down with us again to share new updates in treatment and management of HNSCC.

Click here for the full activity! https://i3health.com/course-information/hnscc-harnessing-immunotherapy-in-comprehensive-care